Liucheng Rong

417 total citations
22 papers, 324 citations indexed

About

Liucheng Rong is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Cancer Research. According to data from OpenAlex, Liucheng Rong has authored 22 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Liucheng Rong's work include Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (4 papers). Liucheng Rong is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (4 papers). Liucheng Rong collaborates with scholars based in China and United States. Liucheng Rong's co-authors include Yongjun Fang, Yao Xue, Peng Wu, Yaping Wang, Meilin Wang, Qin Lu, Na Tong, Zhengdong Zhang, Meiyun Kang and Jie Huang and has published in prestigious journals such as Scientific Reports, Cell Death and Disease and Oncotarget.

In The Last Decade

Liucheng Rong

20 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liucheng Rong China 11 196 149 64 46 37 22 324
Nikki A. Evensen United States 8 212 1.1× 107 0.7× 58 0.9× 17 0.4× 109 2.9× 18 352
Teresa Sadras Australia 10 150 0.8× 61 0.4× 66 1.0× 60 1.3× 37 1.0× 22 301
Marta Jeison Israel 13 178 0.9× 101 0.7× 69 1.1× 18 0.4× 36 1.0× 20 345
Yumiko Kasugai Japan 11 129 0.7× 63 0.4× 32 0.5× 53 1.2× 73 2.0× 20 321
Jiexian Ma China 8 236 1.2× 200 1.3× 20 0.3× 62 1.3× 39 1.1× 18 357
Tatiana Burjanivová Slovakia 10 126 0.6× 76 0.5× 25 0.4× 11 0.2× 61 1.6× 27 262
Yue-Zhong Wu United States 10 416 2.1× 73 0.5× 18 0.3× 45 1.0× 59 1.6× 10 487
Chie Kikutake Japan 10 121 0.6× 59 0.4× 18 0.3× 58 1.3× 54 1.5× 28 284
Jingliao Zhang China 10 140 0.7× 26 0.2× 47 0.7× 50 1.1× 26 0.7× 32 268
Chanatip Metheetrairut Thailand 11 322 1.6× 248 1.7× 29 0.5× 22 0.5× 37 1.0× 21 455

Countries citing papers authored by Liucheng Rong

Since Specialization
Citations

This map shows the geographic impact of Liucheng Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liucheng Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liucheng Rong more than expected).

Fields of papers citing papers by Liucheng Rong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liucheng Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liucheng Rong. The network helps show where Liucheng Rong may publish in the future.

Co-authorship network of co-authors of Liucheng Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Liucheng Rong. A scholar is included among the top collaborators of Liucheng Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liucheng Rong. Liucheng Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huimin, Yidan Zhang, Yidan Zhang, et al.. (2024). Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma. Neoplasia. 52. 100997–100997. 1 indexed citations
3.
Wang, Yaping, Xiaopeng Ma, Huimin Li, et al.. (2024). Plasma-based transcriptomic non-coding signature for predicting relapse in pediatric acute lymphoblastic leukemia. Heliyon. 10(24). e41102–e41102. 1 indexed citations
4.
Kong, Yuanyuan, et al.. (2024). Understanding the unique mechanism of ferroptosis: a promising therapeutic target. Frontiers in Cell and Developmental Biology. 11. 1329147–1329147. 19 indexed citations
5.
Kang, Meiyun, Huimin Li, Liucheng Rong, et al.. (2024). QRICH1 suppresses pediatric T-cell acute lymphoblastic leukemia by inhibiting GRP78. Cell Death and Disease. 15(9). 2 indexed citations
6.
Wei, Yuting, Heng Zhang, Xiaowen Qian, et al.. (2023). Cross-cultural adaptation and validation of the PedsQL™ stem cell transplant module in China: A methodological and cross-sectional study. Frontiers in Pediatrics. 10. 964261–964261. 2 indexed citations
7.
Xue, Yao, Xiaoyan Sun, Liucheng Rong, et al.. (2023). PI3K/AKT pathway‐related microRNA variants in childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 70(10). e30545–e30545. 3 indexed citations
9.
Huang, Jie, Liucheng Rong, Enxiu Wang, & Yongjun Fang. (2020). Pseudoprogression of Extramedullary Disease in Relapsed Acute Lymphoblastic Leukemia After CAR T-cell Therapy. Immunotherapy. 13(1). 5–10. 11 indexed citations
10.
Xue, Yao, et al.. (2019). Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia. BMC Cancer. 19(1). 109–109. 8 indexed citations
11.
Wang, Yaping, Xiaoyun Yang, Xiaoyan Sun, et al.. (2018). Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia. Cell Death and Disease. 9(10). 1043–1043. 28 indexed citations
12.
Ji, Xiaohui, Xiaoyun Yang, Nan Wang, et al.. (2018). Function of SLC7A7 in T-Cell Acute Lymphoblastic Leukemia. Cellular Physiology and Biochemistry. 48(2). 731–740. 13 indexed citations
13.
Zhang, Xuejie, Yang Yan, Liucheng Rong, et al.. (2017). Interleukin-2 and Interleukin-8 Gene Polymorphisms and Acquired Aplastic Anemia Risk in a Chinese Population. Cellular Physiology and Biochemistry. 41(3). 1199–1207. 2 indexed citations
14.
Rong, Liucheng, Guangsheng He, Hailong He, et al.. (2016). Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population. Annals of Hematology. 96(3). 339–344. 4 indexed citations
15.
Lu, Lingling, Yao Xue, Yaping Wang, et al.. (2015). Interaction Between IGF1 Polymorphisms and the Risk of Acute Lymphoblastic Leukemia in Chinese Children. Cellular Physiology and Biochemistry. 36(4). 1346–1358. 13 indexed citations
16.
Wang, Yaping, et al.. (2015). LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Scientific Reports. 5(1). 13749–13749. 88 indexed citations
17.
Li, Qian, Liucheng Rong, Yao Xue, et al.. (2011). hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Science. 102(6). 1123–1127. 25 indexed citations
18.
Huang, Jie, Peng Wu, Qian Li, et al.. (2011). Association of genetic variations inmTORwith risk of childhood acute lymphoblastic leukemia in a Chinese population. Leukemia & lymphoma. 53(5). 947–951. 21 indexed citations
19.
Xue, Yao, Liucheng Rong, Qin Lu, et al.. (2010). The MIF −173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Leukemia Research. 34(10). 1282–1286. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026